Jung-Min Ahn1, Duk-Woo Park1, Cheol Whan Lee2, Mineok Chang1, Rafael Cavalcante3, Yohei Sotomi4, Yoshinobu Onuma3, Erhan Tenekecioglu3, Minkyu Han5, Pil Hyung Lee1, Soo-Jin Kang1, Seung-Whan Lee1, Young-Hak Kim1, Seong-Wook Park1, Patrick W Serruys6, Seung-Jung Park1. 1. Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan, Seoul, Korea. 2. Division of Cardiology, Heart Institute, Asan Medical Center, University of Ulsan, Seoul, Korea. Electronic address: cheolwlee@amc.seoul.kr. 3. Erasmus University Medical Center, Amsterdam, the Netherlands. 4. Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands. 5. Division of Biostatistics, Asan Medical Center, University of Ulsan, Seoul, Korea. 6. Erasmus University Medical Center, Amsterdam, the Netherlands; International Center for Circulatory Health, Imperial College of London, London, United Kingdom.
Abstract
OBJECTIVES: The aim of this study was to compare long-term survival between patients with severe coronary artery disease undergoing coronary artery bypass grafting (CABG) and those undergoing percutaneous coronary intervention (PCI) achieving complete revascularization (CR) or incomplete revascularization. BACKGROUND: The importance of CR in decision making regarding revascularization strategy in patients with severe coronary artery disease is unknown. METHODS: Data were pooled from the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trials. The primary outcome was death from any cause and was compared in an as-treated analysis. RESULTS: The rate of CR was 61.7% (57.2% with PCI and 66.8% with CABG). During a median 4.9-year follow-up period (interquartile range: 4.5 to 5.0 years), compared with patients undergoing CABG with CR, those undergoing PCI with incomplete revascularization had a higher risk for death from any cause (adjusted hazard ratio [aHR]: 1.43; 95% confidence interval [CI]: 1.03 to 2.00; p = 0.036) and the composite of death, myocardial infarction, and stroke (aHR: 1.48; 95% CI: 1.14 to 1.92; p = 0.003). However, there was no significant difference between patients undergoing CABG with CR and those undergoing PCI with CR regarding the risk for death from any cause (aHR: 1.16; 95% CI: 0.83 to 1.63; p = 0.39) and the composite of death, myocardial infarction, and stroke (aHR: 1.14; 95% CI: 0.87 to 1.48; p = 0.35). Subgroup analysis of multivessel coronary disease, high SYNTAX score (>32), and diabetes showed consistent findings. CONCLUSIONS: For the treatment of left main or multivessel coronary artery disease, PCI resulting in CR was associated with a similar long-term survival rate to CABG resulting in CR. Therefore, the ability to achieve CR should enter into the decision algorithm for choice of revascularization strategy.
OBJECTIVES: The aim of this study was to compare long-term survival between patients with severe coronary artery disease undergoing coronary artery bypass grafting (CABG) and those undergoing percutaneous coronary intervention (PCI) achieving complete revascularization (CR) or incomplete revascularization. BACKGROUND: The importance of CR in decision making regarding revascularization strategy in patients with severe coronary artery disease is unknown. METHODS: Data were pooled from the SYNTAX (Synergy Between PCI With Taxus and Cardiac Surgery), PRECOMBAT (Premier of Randomized Comparison of Bypass Surgery Versus Angioplasty Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease), and BEST (Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease) trials. The primary outcome was death from any cause and was compared in an as-treated analysis. RESULTS: The rate of CR was 61.7% (57.2% with PCI and 66.8% with CABG). During a median 4.9-year follow-up period (interquartile range: 4.5 to 5.0 years), compared with patients undergoing CABG with CR, those undergoing PCI with incomplete revascularization had a higher risk for death from any cause (adjusted hazard ratio [aHR]: 1.43; 95% confidence interval [CI]: 1.03 to 2.00; p = 0.036) and the composite of death, myocardial infarction, and stroke (aHR: 1.48; 95% CI: 1.14 to 1.92; p = 0.003). However, there was no significant difference between patients undergoing CABG with CR and those undergoing PCI with CR regarding the risk for death from any cause (aHR: 1.16; 95% CI: 0.83 to 1.63; p = 0.39) and the composite of death, myocardial infarction, and stroke (aHR: 1.14; 95% CI: 0.87 to 1.48; p = 0.35). Subgroup analysis of multivessel coronary disease, high SYNTAX score (>32), and diabetes showed consistent findings. CONCLUSIONS: For the treatment of left main or multivessel coronary artery disease, PCI resulting in CR was associated with a similar long-term survival rate to CABG resulting in CR. Therefore, the ability to achieve CR should enter into the decision algorithm for choice of revascularization strategy.
Authors: Janusz Konstanty-Kalandyk; Jacek Piątek; Anna Kędziora; Krzysztof Bartuś; Rafał Drwila; Tomasz Darocha; Grzegorz Filip; Bogusław Kapelak; Bryan HyoChan Song; Jerzy Sadowski Journal: Lasers Med Sci Date: 2018-05-07 Impact factor: 3.161
Authors: Deborah H Kwon; Nancy A Obuchowski; Thomas H Marwick; Venu Menon; Brian Griffin; Scott D Flamm; Rory Hachamovitch Journal: J Am Heart Assoc Date: 2018-11-20 Impact factor: 5.501
Authors: Kyu Kim; Choongki Kim; Byeong Keuk Kim; Ji Yong Jang; Ae Young Her; Seunghwan Kim; Sung Jin Hong; Chul Min Ahn; Jung Sun Kim; Young Guk Ko; Donghoon Choi; Myeong Ki Hong; Yangsoo Jang Journal: Yonsei Med J Date: 2018-06 Impact factor: 2.759